Schnieders Capital Management LLC Makes New Investment in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Schnieders Capital Management LLC purchased a new position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,456 shares of the financial services provider’s stock, valued at approximately $219,000.

Several other institutional investors have also modified their holdings of the business. Mercer Global Advisors Inc. ADV lifted its stake in shares of iShares Nasdaq Biotechnology ETF by 53.6% during the 1st quarter. Mercer Global Advisors Inc. ADV now owns 2,520 shares of the financial services provider’s stock worth $379,000 after purchasing an additional 879 shares during the period. Essex Financial Services Inc. increased its holdings in shares of iShares Nasdaq Biotechnology ETF by 5.8% during the 1st quarter. Essex Financial Services Inc. now owns 6,585 shares of the financial services provider’s stock worth $991,000 after buying an additional 362 shares during the last quarter. WealthPLAN Partners LLC increased its holdings in shares of iShares Nasdaq Biotechnology ETF by 3.4% during the 1st quarter. WealthPLAN Partners LLC now owns 30,573 shares of the financial services provider’s stock worth $4,594,000 after buying an additional 1,019 shares during the last quarter. Cookson Peirce & Co. Inc. acquired a new stake in shares of iShares Nasdaq Biotechnology ETF during the 1st quarter worth $283,000. Finally, First Horizon Advisors Inc. increased its holdings in shares of iShares Nasdaq Biotechnology ETF by 37.1% during the 1st quarter. First Horizon Advisors Inc. now owns 3,020 shares of the financial services provider’s stock worth $454,000 after buying an additional 818 shares during the last quarter. 75.58% of the stock is currently owned by institutional investors.

IBB stock opened at $160.51 on Thursday. The business’s fifty day moving average price is $151.76. iShares Nasdaq Biotechnology ETF has a 52 week low of $125.18 and a 52 week high of $174.04.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Article: How are capital gains distributions different for tax-deferred account?

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.